Noradrenergic neuromodulation in ageing and disease

Area of Science:

• Neuroscience
• Neurobiology
• Neuropathology

Background:

• The locus coeruleus (LC) is a key brainstem nucleus, serving as the primary source of noradrenaline (NA) in the brain.
• NA modulates critical functions including cognition, autonomic control, and immune responses.
• The role of LC degeneration in healthy aging and its contribution to neurodegenerative diseases like Alzheimer's (AD) and Parkinson's (PD) requires further elucidation.

Purpose of the Study:

• To review the mechanisms underlying LC degeneration in aging, AD, and PD.
• To highlight the potential role of early noradrenergic system dysfunction in the pathogenesis of AD and PD.
• To stimulate research into the broader relevance of LC degeneration in other neurodegenerative conditions.

Main Methods:

• This is a review article, synthesizing existing research on the locus coeruleus and neurodegeneration.
• Mechanisms of LC degeneration in aging, AD, and PD are examined.
• The link between noradrenergic dysfunction and early behavioral symptoms in neurodegenerative diseases is discussed.

Main Results:

• The extent of LC degeneration in healthy aging is not fully understood.
• Noradrenergic dysfunction is implicated in the pathogenesis of AD and PD.
• Early LC involvement may explain shared preclinical symptoms (e.g., sleep disturbances, neuropsychiatric issues) in AD and PD.

Conclusions:

• Early degeneration of the noradrenergic system, originating in the LC, may be a pivotal factor in the pathogenesis of AD and PD.
• Understanding LC degeneration mechanisms is crucial for developing early diagnostic and therapeutic strategies for neurodegenerative diseases.
• The findings have implications for a wider range of neurodegenerative disorders beyond AD and PD.